Delivery Order SPE2DB22D2108-SPE2DB24FU3LB
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide MICARDIS HCT 80-25 mg tablet prescriptions. The contract, valued at $1,294.00, has a performance period through March 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, serves as the prime contractor...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,037.76 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S. The contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award and does not have any major subcontractors identified. This delivery order is part of a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MICARDIS HCT 80-25 MG TABLET UD 30S. The $1,195.27 delivery order was awarded on March 15, 2022 with a completion date of March 16, 2022. Amerisourcebergen Drug Corp, a large for-profit pharmaceutical distributor, has held numerous previous contracts with DLA to supply pharmaceuticals, medical supplies,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MICARDIS HCT 40-12.5 MG TABLET UD 30S pharmaceutical products. The contract has an ultimate completion date of April 15, 2024 and a ceiling value of $4,151.04. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,037.76 to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of MICARDIS HCT 40-12.5 mg tablets, a medication used to treat high blood pressure. This order is placed against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,436.94 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, with a completion date of February 6, 2024. This delivery order contract is issued under a larger, single-award indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at...
- The Department of Defense (DoD) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of MICARDIS HCT 80-25 MG TABLET UD 30S. The contract, valued at $4,323.27, is being administered by the Defense Logistics Agency (DLA) Troop Support Medical and has a period of performance through January 31, 2024. This delivery order contract is part of a larger, single-award indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $1,989.04 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. This order, which does not have a set-aside designation, is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a brand name pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,818.62 to AmerisourceBergen Drug Corp for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product. The contract has a firm fixed price of $2,822.06 and a completion date of October 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not set aside. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB24FU3LBDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,037.48 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 and with a performance period through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 3/11/24 |